<DOC>
	<DOCNO>NCT00729846</DOCNO>
	<brief_summary>To evaluate safety , visual acuity outcome , persistence choroidal neovascular leakage , number treatment combination intravitreal bevacizumab verteporfin photodynamic therapy standard reduce fluence level patient subfoveal CNV due age-related macular degeneration .</brief_summary>
	<brief_title>Bevacizumab Combination With Visudyne Photodynamic Therapy ( PDT )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>Patients men woman age 50 old . Patients receive previous treatment subfoveal choroidal neovascularization ( CNV ) . Patients must evidence active recurrent subfoveal CNV confirm fluorescein angiography . The total lesion must less equal 9 disc area size , great linear distance 5400 micron . Best correct visual acuity , use ETDRS chart , 20/40 20/320 ( Snellen equivalent ) study eye . Only one eye assess study . The CNV lesion must primarily CNV ( i.e . CNV equal great 50 % lesion . The CNV associate macular degeneration . Patient defers approve treatment subfoveal CNV associate AMD . Prior treatment subfoveal choroidal neovascularization ( CNV ) . Prior treatment juxtafoveal extrafoveal CNV involve previous antiangiogenic agent , photodynamic therapy , intravitreal triamcinolone acetate . History vitrectomy submacular surgery study eye . Subretinal fibrosis account 50 % lesion . NonCNV lesion component account 50 % total lesion component . CNV due cause AMD . Retinal pigment epithelial tear involve center macula . Geographic atrophy involve central macula . Any concurrent intraocular condition study eye opinion investigator could require surgical medical intervention course study ( i.e . cataract ) . Active intraocular inflammation . Vitreous hemorrhage eye . History spherical equivalent study eye great negative 8 diopter . Intraocular surgery within 2 month study enrollment . Uncontrolled glaucoma study eye . Defined intraocular pressure great 30mmHg despite treatment antiglaucoma medication . History disease , recent myocardial infarction , recent cerebral vascular accident , uncontrolled hypertension opinion investigator might render subject high risk complication . Inability comply study followup procedure .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>choroidal neovascularization</keyword>
	<keyword>macular degeneration</keyword>
	<keyword>macular edema</keyword>
	<keyword>intravitreal bevacizumab</keyword>
	<keyword>vegf</keyword>
	<keyword>verteporfin PDT</keyword>
</DOC>